Advertisement

Drug Safety

, Volume 31, Issue 10, pp 885–885 | Cite as

Psychiatric Disorders with Anti-TNFalpha Treatment: An Adverse Drug Reaction to Keep in Mind

  • H. Théophile
  • B. Debray
  • G. Miremont-Salamé
  • E. Shipley
  • T. Schaeverbeke
  • F. Haramburu
Abstract

Keywords

Psychiatric Disorder Infliximab Etanercept Adverse Drug Reaction Juvenile Idiopathic Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kaufman KR. Etanercept, anticytokines and mania. Int Clin Psychopharmacol 2005; 20: 239–41PubMedCrossRefGoogle Scholar
  2. 2.
    Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342: 763–9PubMedCrossRefGoogle Scholar
  3. 3.
    Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during antitumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001; 44: 2862–9PubMedCrossRefGoogle Scholar
  4. 4.
    Quartier P, Taupin P, Bourdeaut F, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003; 48: 1093–101PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • H. Théophile
    • 1
  • B. Debray
    • 2
  • G. Miremont-Salamé
    • 3
  • E. Shipley
    • 2
  • T. Schaeverbeke
    • 2
  • F. Haramburu
    • 3
  1. 1.Centre de PharmacovigilanceCHUBordeauxFrance
  2. 2.Service de RhumatologieCHUBordeauxFrance
  3. 3.Centre de PharmacovigilanceCHUBordeauxFrance

Personalised recommendations